Insiders Cantargia AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 16:29:34 15/05/2024 BST			5-day change	1st Jan Change
3.54 ^SEK	-1.23%		-1.94%	-5.30%

04-17	Cantargia Publishes New Data on the Can10 Antibody, Detailing Its Interaction with IL1RAP and Functional Inhibition	CI
04-10	Cantargia AB Publishes Preclinical Data on the Potential of CAN10 in Systemic Sclerosis in A Leading Scientific Journal	CI

Cantargia AB Promotes David Liberg to Chief Scientific Officer	01/06/23	CI
Cantargia : The nomination committees statement	24/04/23	PU
Cantargia Appoints Patrik Renblad as Chief Financial Officer	01/02/23	CI
Cantargia AB Announces Nomination Committee Appointments	21/11/22	CI
Nomination Committee appointed ahead of 2023 Annual General Meeting	21/11/22	AQ
Cantargia AB Announces Executive Changes	08/07/22	CI
Cantargia AB Strengthens Executive Management in Preparation for Late-Stage Clinical Development	10/03/22	CI
(R) Nomination Committee appointed ahead of 2022 Annual General Meeting	29/10/21	PU
Nomination Committee appointed ahead of 2022 Annual General Meeting	29/10/21	AQ
Cantargia AB Announces Appointment of Nomination Committee	29/10/21	CI
Cantargia AB Elect Magnus Nilsson and Damian Marron as New Board Members	26/05/21	CI
Cantargia AB Announces Claus Asbjørn Andersson Declined Re-Election	27/04/21	CI
Cantargia : Changes to Cantargia’s nomination committee	21/12/20	PU
Cantargia : Changes to Cantargia's nomination committee	21/12/20	AQ
Cantargia AB Announces Nomination Committee Changes	21/12/20	CI
Cantargia AB Announces Executive Changes	20/10/20	CI
Cantargia : Nomination Committee appointed ahead of 2021 Annual General Meeting	20/10/20	PU
Cantargia : Nomination Committee appointed ahead of 2021 Annual General Meeting	20/10/20	AQ
Cantargia : Cantargia’s nomination committee proposes a new board member	21/09/20	PU
Cantargia : nomination committee proposes a new board member	21/09/20	AQ

No results for this search